Delivery Order SPE2DB20D1102-SPE2DB25FC6PW
Award Date 7/21/25
Potential Completion Date 7/22/25
Potential Value $4.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,126.62 to AmerisourceBergen Drug Corp for Adbry 150 mg/mL syringes on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,321.32 on July 25, 2025, for the supply of Abyrysvo vial with diluent syringes. This firm fixed price delivery order, with an ultimate completion date of July 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX. The contract was competitively awarded with no set-aside designation and will be performed...
- The U.S. Defense Logistics Agency (DLA) awarded a $9,201.62 firm-fixed price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of ADBRY 150 MG/ML SYRINGEML, a medical product, with a completion date of April 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to provide a broad range...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of a pharmaceutical product - ADBRY 150 MG/ML SYRINGEML. The order has a ceiling value of $17,638.32 and a period of performance through August 13, 2024. It is issued under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical valued at up to $999,999,999, which provides a broad range of medical commodities to support military...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $44,648.74 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, with an ultimate completion date of July 22, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is classified as a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $38,238.54 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order represents a non-competitive award and constitutes a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,563.00 by the Defense Logistics Agency's Medical Supply Chain on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside designation...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $26,316.62 by the Defense Logistics Agency's Medical Supply Chain on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed price, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be performed at AmerisourceBergen's corporate...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,589.43 to AmerisourceBergen Drug Corp on July 26, 2025, with ultimate completion by July 28, 2025. This firm fixed-price, non-set-aside delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $144,644.38 by the Defense Logistics Agency Medical Supply Chain on July 21, 2025, with an ultimate completion date of July 22, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...